Latest in Cell & Gene Therapy

Limula bags US patent for cell & gene therapy manufacturing technology

The automated technology is designed to streamline the cell and gene therapy production process, paving the way for point-of-care manufacturing within hospital facilities

Find out more

Omron and Cognizant to offer IT/OT integration services to pharmaceutical manufacturers

Together, Omron and Cognizant will help manufacturers to integrate IT-OT into their operations and maintenance processes
See more
You need to be a subscriber to read this article.
Click here to find out more.

Engineering the future of bispecific antibody therapeutics

During the past decade, bispecific antibodies (bsAbs) have garnered growing interest among drug developers. This technology has opened the door to new therapeutic applications and mechanisms of action

Charles River Laboratories names Advanced Therapy Incubator Programme cohort

The programme is designed to support early-stage biotech companies in getting their biologic or cell & gene therapy products and technologies to market
You need to be a subscriber to read this article.
Click here to find out more.

Bringing CAR-T therapy within reach: how decentralised manufacturing will improve patient access

By offering a lifeline to patients with otherwise untreatable conditions, CAR-T cell therapy has transformed cancer treatment. Yet, despite the breakthrough potential of these patient-specific therapies, access remains severely limited
You need to be a subscriber to read this article.
Click here to find out more.

Three areas of genomic medicine benefiting from the sequencing tech revolution

One of the great challenges of modern medicine, despite significant advances in many therapeutic areas, is that some diseases remain stubbornly difficult to treat. Neil Ward, Vice President, EMEA, at PacBio, investigates

Clean Cells acquires cytogenic testing specialist, Karyologic

The strategic acquisition will expand Clean Cells' US footprint, while allowing the company to offer karyotyping services to its North American clients

Newly established CDMO kicks off operations with Landmark Bio acquisition

Artis BioSolutions, a new CDMO focused on genetic medicines, has acquired Landmark Bio to offer its clients comprehensive, end-to-end advanced therapy manufacturing services

ACG Biologics launches Cell and Gene Technologies Division

The CDMO's division will be responsible for assisting the biopharmaceutical industry in developing and commercialising cell and gene therapies at a competitive cost

Optimising early-stage drug development with continuous processing

Pharmaceutical innovators face many challenges when developing new products; as such, getting them to market in a timely, safe and cost-effective way is critical. The use of continuous manufacturing technologies can help to overcome some of the most pressing early-stage obstacles

Latest posts in Cell & Gene Therapy

Opening new doors to precision medicine with single-stranded DNA (ssDNA): part II

In the second part of this article, the benefits of ssDNA in terms of efficient cellular uptake and stability, the application of self-folding nanocarriers for gene delivery and mechanisms of action are discussed, along with a forward-thinking review of future perspectives and challenges

Opening new doors to precision medicine with single-stranded DNA (ssDNA): part I

In this two-part article, the science behind ssDNA manufacturing is explored, along with the innovations that are enhancing the therapeutic benefits of ssDNA-derived constructs. A comparative analysis of traditional double-stranded DNA (dsDNA) and other nucleic acid-based methods is also included

Limula touts benefits of optoporation in cell therapy manufacturing in new Cell Press article

Limula suggests that using high-intensity lasers with magnetic particle catalysts in the mRNA CAR-T cell manufacturing can streamline production methods

Andelyn Biosciences and Broad Institute of MIT and Harvard expand CGT R&D partnership

The CDMO's AAV Curator Platform will now incorporate the Broad Institute's Stanton Lab CNS capsids, which are up to 6x more effective at targeting most areas of the cerebrum

AskBio's Parkinson's gene therapy, AB-1005, receives FDA RMAT designation

The Bayer subsidiary is currently recruiting for the Phase II REGENERATE-PD trial, which will assess AB-1005's potential in slowing Parkinson's disease progression and improving motor outcomes

SGS launches commercial cell sorting service for the German biopharmaceutical market

The fluorescent-activated cell sorting (FACS) service is the first commercial service of its sort to reach the German biopharmaceutical market

Cytiva and Cellular Origins team up to advance the cell and gene therapy manufacturing process

By combining Cytiva's Sefia platform with Cellular Origins' automated Constellation platform, the two will help its customers to efficiently scale up CGT production to industrial levels

Terumo BCT and FUJIFILM Ivrine Scientific team up to accelerate T-cell expansion

Via Fujifilm's PRIME XV T-cell Expansion Media and Terumo BCT's Quantum Flex Cell Expansion System, the companies can reduce the cost, time and complexity of the T-cell expansion process

Astraveus achieves end-to-end CAR-T production for the first time in history

The Lakhesys Benchtop Cell Factory utilises advanced microfluidic technology to produce CAR-T cells in a rapid and cost-effective manner

PCR-ELISA proves problematic in gene therapy measurement, determines NIST study

PCR-ELISA was considered the least accurate and precise assay when quantifying the concentration of genetic and viral particles in an AAV, suggesting it may not be suitable for gene therapy measurement in its current form

Quantoom Biosciences, Univercells and Fiocruz collaborate to advance global RNA vaccine development

Together, the companies will develop RNA-based biopharmaceuticals, while also building a dedicated mRNA production facility in Brazil

Servier opens new €86m biologics production facility in Loiret, France

The company's Bio-S facility will be responsible for the production of biological medicines stemming from its R&D pipeline for preclinical and clinical studies

Sponsor content

AnalytiChem debuts branded Redipor culture media

The branded culture media line combines the expertise of BioTrading, Redipor by Cherwell and NEL to provide customers with tailored batch sizes, formulations and packaging...

Merck launches single-use reactor designed to accelerate antibody drug conjugate manufacturing

First scalable single-use mixer specifically designed for ADC manufacturing. It increases efficiency by 70% compared to stainless steel or glass manufacturing methods and...

Cell culture bags - Understanding the basics

Uncover the benefits of cell culture bags and why they could be the ideal solution for your cell processing application.

Symbiosis Pharmaceutical Services shares the industry events it will attend in 2024

The aseptic manufacturing specialists will have an exhibiting presence at an additional 5 events globally this year

CordenPharma launches lipid nanoparticle starter kits

The kits will aid in loss mitigation of high-value payloads during the gene editing journey to market

COVID-19: a tale of two conditions

The virus coronavirus SARS CoV-2 (severe acute respiratory syndrome coronavirus 2), which causes COVID-19, may have been named prematurely, reports Steve Walton, who works...

RNA therapeutics to become a dominant treatment within a decade

New white paper from the Chinese pharma WuXi AppTec features industry experts pointing to the beginnings of a new era for RNA therapeutics

DNA sequencer uses naturally occurring light for ultra precise positioning

Light generated by the natural process of DNA replication provides the user with exceptionally high resolution and low pass noise filtering when using the encoder

Metrion Biosciences and Peakdale Molecular sign integrated drug discovery partnership

Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries and part of the Concept Life Sciences Group, has...

Lion Biotechnologies announces new manufacturing services agreement with WuXi AppTec

Scientists Successfully Create Blood from Skin Cells

Researchers in Singapore have artificially generated new mouse blood and immune cells from skin cells.

Featured companies

CPTx is pioneering in vivo production of precision genetic medicines using single-stranded DNA.
See more